18 Members•4,119 Posts

Pharma & Biotech

Nexsen secures first hospital partner in Asia with GHK collaboration

May 13, 2026

Jonathan Jackson

Imugene valuation points to 129% upside as broker backs azer-cel strategy

May 13, 2026

Jonathan Jackson

Anteris adds Susan Knight, Stephen Denaro to board as company advances heart valve strategy

May 13, 2026

Jonathan Jackson

Small Cap Watch: Atomic Eagle expands uranium zone, RMI prepares Tanzania drilling, Anteris advances DurAVR trial

May 13, 2026

Lisa Uhlman

BioHarvest Sciences advances synthetic saffron program with SaffronTech partnership

May 13, 2026

Angela Harmantas

Anteris advances PARADIGM trial as Q1 cash burn reflects commercialisation push

May 13, 2026

Jonathan Jackson

Immunic advances Phase 3 MS program, eyes topline data by year-end

May 13, 2026

Emily Jarvie

Faron Pharma to present bexmarilimab blood cancer data at EHA congress

May 13, 2026

Ian Lyall

Poolbeg Pharma to present POLB 001 data at European Hematology Association congress

May 13, 2026

Ian Lyall

Enlivex advances Allocetra while expanding into prediction markets

May 12, 2026

Steve Darling

Biome extends Probiotical supply agreement through to 2028

May 12, 2026

Jonathan Jackson

AtaiBeckley targets Q2 start for Phase 3 depression trial as pipeline advances

May 12, 2026

Emily Jarvie

BioHarvest Sciences wins $1.2M fragrance contract

May 12, 2026

Angela Harmantas

CelLBxHealth targets growth after £6.6m cost-cutting overhaul

May 12, 2026

Stephen Gunnion

IXICO launches latest version of AI neuroimaging platform

May 12, 2026

Ian Lyall

Enlivex advances Allocetra while expanding into prediction markets

May 11, 2026

Steve Darling

Novo Nordisk GLP-1 pill launch impresses but price erosion keeps Citi on the sidelines

May 11, 2026

Ian Lyall

Moderna shares extend gains as hantavirus vaccine work draws attention

May 11, 2026

Emily Jarvie

Acrux raises $1.6 million to fund female testosterone development

May 11, 2026

Jonathan Jackson

CelLBxHealth shares jump 17% as strategic deals and cost reset lift sentiment

May 11, 2026

Ian Lyall

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy